The digital health developer has now raised some $350m from investors including Novartis, Otsuka, Oracle, Medtronic, St Jude's Medical, Kaiser Permanente and ON.
Proteus Digital Health, the US-based digital medicine technology developer backed by a range of corporate investors, raised $50m in series H financing on Friday from undisclosed investors.
Proteus is working on a wide range of digital medicine products based on its Proteus Discover platform, and the funding will be used to increase the system’s adoption by health systems.
Products being developed through Proteus Discover include wearable sensors that track the body’s response to drugs, medicines that signal when they have…